ENLDB.AU Chess Depositary Interests 1:1 Us Prohibited Defer
- Market cap
- AUD 26.9M
- P/E
- -
- P/B
- 3.90x
- ROE
- -328.0%
- Dividend yield
- -
- Fundamental score
- 0.4/5
Ratios use the latest price and the fiscal year ending Dec 2025.
Is ENLDB.AU undervalued?
Graham numberThe Graham number of Chess Depositary Interests 1:1 Us Prohibited Defer cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Chess Depositary Interests 1:1 Us Prohibited Defer fundamental analysis
2 of 21 checks passedROE 0/2
Low return on equity (-328.0%), below 10%.
ROA 0/1
Return on assets (-149.3%) is below the industry median (-82.9%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (94.4%) is above the industry median (-16.0%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.2 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (3.9x) is above the industry median (1.8x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Chess Depositary Interests 1:1 Us Prohibited Defer stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Chess Depositary Interests 1:1 Us Prohibited Defer
Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization…
Full company profileChess Depositary Interests 1:1 Us Prohibited Defer financial statements
Chess Depositary Interests 1:1 Us Prohibited Defer annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 496K | 1.08M | 3.80M |
| Gross Profit | 496K | 1.08M | 3.80M |
| Operating Income | -15.6M | -15.9M | -13.4M |
| EBITDA | -15.1M | -15.1M | -12.6M |
| Net Income | -15.6M | -15.2M | -13.4M |
| EPS | -0.18 | -0.26 | -0.01 |
| Balance Sheet | |||
| Total Assets | 11.6M | 14.2M | 8.96M |
| Total Liabilities | 633K | 3.17M | 4.88M |
| Shareholders' Equity | 10.9M | 11.0M | 4.08M |
| Cash & Short-term Investments | 11.1M | 7.16M | 2.57M |
| Cash Flow | |||
| Capital Expenditure | 4.58K | 20.9K | 12.9K |
| Free Cash Flow | -14.9M | -15.2M | -11.8M |
| Ratios | |||
| ROE | -142.1% | -138.2% | -328.0% |
| ROA | -134.4% | -107.3% | -149.3% |
| Net Profit Margin | -3,135.9% | -1,412.4% | -352.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Chess Depositary Interests 1:1 Us Prohibited Defer dividends
Chess Depositary Interests 1:1 Us Prohibited Defer has not paid dividends in the last 4 fiscal years.
Last stock split: 1:10 on Sep 11, 2026.
Who owns Chess Depositary Interests 1:1 Us Prohibited Defer
Ownership data of Chess Depositary Interests 1:1 Us Prohibited Defer is not available yet.
Chess Depositary Interests 1:1 Us Prohibited Defer company profile
- Company name
- Chess Depositary Interests 1:1 Us Prohibited Defer
- Ticker
- ENLDB.AU
- ISIN
- AU0000488934
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Information Services
- Fiscal year end
- December
- Address
- 1635 Foxtrail Drive, Loveland, CO, United States, 80538
- Phone
- 877-365-4842
- Website
- enlitic.com
About Chess Depositary Interests 1:1 Us Prohibited Defer
Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.
Chess Depositary Interests 1:1 Us Prohibited Defer management
4- Mr. Darren ScottiCFO & Company Secretary
- Mr. Dan KozimorChief Technology Officer
- Mr. Scott StantonVice President of Sales Operations
- Mr. Steve RankinChief Strategy Officer